Hermetica Superfood Encyclopedia
The Short Answer
Dehydroabietic acid (DHAA) is a diterpene resin acid derived from pine trees that exhibits potent anticancer properties. It induces cancer cell death through mitochondrial pathways and survivin protein suppression, demonstrating superior cytotoxicity compared to standard chemotherapy agents.
CategoryNamed Bioactive Compounds
GroupCompound
Evidence LevelModerate
Primary Keyworddehydroabietic acid benefits
Synergy Pairings3
Dehydroabietic Acid (Diterpene Resin Acid) — botanical close-up
Health Benefits
Origin & History
Natural habitat
Dehydroabietic acid (DHAA) is a diterpene resin acid derived from pine tree resins, particularly found in colophony (rosin), and belongs to the abietane diterpene class of compounds. It is one of the major components of pine resin alongside abietic acid and is typically extracted through standard isolation and purification procedures from pine resin sources.
“The research provides no information regarding traditional medicinal use of dehydroabietic acid. While identified as a natural constituent of pine resin, no historical applications in traditional medicine systems are documented in the available sources.”Traditional Medicine
Scientific Research
Available evidence consists entirely of in vitro laboratory studies and animal models, with no human clinical trials or PMIDs identified in the research. Key studies demonstrated DHAA derivatives achieving IC₅₀ values of 6.58 μM against HeLa cells compared to 36.58 μM for 5-fluorouracil, and significant viability reduction in six gastric cancer cell lines.
Preparation & Dosage
Traditional preparation
No clinically studied dosage ranges for human use are available. In vitro studies used concentrations of 10-15 μM for cell culture experiments, but these cannot be translated to human dosing. No standardized extract formulations or human dosage recommendations exist. Consult a healthcare provider before starting any new supplement.
Nutritional Profile
Dehydroabietic Acid (DHAA) is a pure bioactive diterpene resin acid compound (molecular formula C20H30O2, molecular weight 300.44 g/mol), not a food or nutritional ingredient. Therefore, it does not possess conventional macronutrient, micronutrient, vitamin, mineral, or fiber content. What IS known: (1) Bioactive compound classification: Abietane-type tricyclic diterpene with an aromatic C-ring, phenanthrene skeleton, and a carboxylic acid functional group at C-4 position. (2) Concentration in source material: Found naturally in pine rosin and conifer-derived resins at concentrations of approximately 10–30% of total resin acid fraction; occurs as a primary oxidation product of abietic acid. (3) Lipophilicity: High lipophilicity (estimated LogP ~5.5–6.0), contributing to membrane permeability and bioavailability in lipid-rich environments; poorly water-soluble (<0.1 mg/mL in water), requiring formulation strategies (nanoparticles, derivatives) to enhance bioavailability. (4) Thermal stability: Stable up to approximately 170°C before significant degradation. (5) Bioavailability notes: Oral bioavailability of unmodified DHAA is limited due to poor aqueous solubility and rapid hepatic metabolism; esterification and amide derivatives (e.g., DHAA-glycine conjugates) significantly improve cellular uptake and cytotoxic potency in vitro. No caloric value, protein, carbohydrate, fat, or micronutrient content is applicable to this compound in isolation.
How It Works
Mechanism of Action
Dehydroabietic acid induces apoptosis in cancer cells by disrupting mitochondrial membrane potential and triggering cytochrome c release. The compound suppresses survivin protein expression, a key anti-apoptotic factor that helps cancer cells resist programmed death. DHAA derivatives activate caspase-dependent pathways while simultaneously inhibiting cellular proliferation through cell cycle arrest mechanisms.
Clinical Evidence
Current research on dehydroabietic acid is limited to in vitro studies examining its anticancer potential. Laboratory studies demonstrate that DHAA derivatives show superior cytotoxicity against cervical, ovarian, and gastric cancer cell lines compared to 5-fluorouracil, a standard chemotherapy drug. The evidence remains preliminary, with no human clinical trials or animal studies published to date. Further research is needed to determine therapeutic dosages, bioavailability, and real-world efficacy in cancer treatment.
Safety & Interactions
Safety data for dehydroabietic acid supplementation is extremely limited due to lack of human studies. As a pine-derived resin acid, it may cause allergic reactions in individuals sensitive to pine products or terpenes. No drug interactions have been documented, but theoretical concerns exist regarding interference with chemotherapy protocols given its potent cellular effects. Pregnant and breastfeeding women should avoid DHAA supplements due to insufficient safety data and unknown effects on fetal development.
Synergy Stack
Hermetica Formulation Heuristic
Frequently Asked Questions
What is dehydroabietic acid derived from?
Dehydroabietic acid is a diterpene resin acid naturally extracted from pine tree resins, particularly from species like Pinus species. It represents one of the major bioactive compounds found in rosin and pine-derived materials used in traditional medicine.
How does dehydroabietic acid compare to 5-fluorouracil for cancer?
In vitro studies show DHAA derivatives demonstrate superior cytotoxicity against cervical, ovarian, and gastric cancer cell lines compared to 5-fluorouracil, a standard chemotherapy drug. However, this comparison is limited to laboratory studies and does not reflect real-world clinical effectiveness.
What cancer types has dehydroabietic acid been studied for?
Laboratory research has focused on dehydroabietic acid's effects against cervical, ovarian, and gastric cancer cell lines. The compound shows particular promise in inducing apoptosis in these specific cancer types through mitochondrial pathway disruption.
Are there any dehydroabietic acid supplements available?
Dehydroabietic acid is not commonly available as a standalone dietary supplement due to limited safety data and lack of human studies. Most commercial availability is restricted to research-grade compounds for laboratory use rather than consumer supplements.
What are the side effects of dehydroabietic acid?
Side effects of dehydroabietic acid are largely unknown due to absence of human clinical trials. Potential concerns include allergic reactions in pine-sensitive individuals and unknown interactions with medications, particularly chemotherapy drugs given its potent cellular effects.
What is the current research quality and evidence strength for dehydroabietic acid as a potential cancer treatment?
Current evidence for dehydroabietic acid is limited to preliminary in vitro studies and animal research, with no completed human clinical trials published to date. While laboratory findings show promising cytotoxicity against cervical, ovarian, and gastric cancer cell lines, these results cannot be directly translated to clinical efficacy in patients. More rigorous preclinical studies and human trials are needed before dehydroabietic acid can be considered an established therapeutic agent. Consumers should be cautious of marketing claims that overstate the significance of early-stage laboratory research.
Who should avoid dehydroabietic acid supplementation, and are there specific populations at higher risk?
Dehydroabietic acid should be avoided by pregnant and nursing women due to lack of safety data, and individuals with active cancer should consult oncologists before use given the preliminary nature of research. People taking chemotherapy drugs or immunosuppressants should avoid this ingredient without medical supervision, as potential interactions are not well-studied. Additionally, those with tree resin allergies or sensitivities may experience adverse reactions, since dehydroabietic acid is derived from natural resin sources.
How does dehydroabietic acid's mechanism of action compare to conventional anticancer mechanisms used in standard medicine?
Dehydroabietic acid appears to induce cancer cell death through mitochondrial apoptotic pathways and survivin inhibition, mechanisms similar to some conventional chemotherapies but studied only in laboratory settings. Unlike 5-fluorouracil, which disrupts DNA synthesis and is widely used clinically, DHAA's therapeutic potential remains experimental with no established dosing or clinical protocols. The diterpene resin acid's selectivity for cancer cells versus healthy tissue and its toxicity profile in humans remain largely unknown, making direct mechanism comparison to approved drugs incomplete.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w dehydroabietic-acid curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
